Therapy in the Setting of Genetic Predisposition to Cancer

Handbook of Psychotherapy in Cancer Care

Volumn , Issue , 2011, Pages 199-212

  Jane Esplen, Mary ^a,b,d   Hunter, Jonathan ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d De Souza Institute   (Canada)

Author keywords

Cognitive behavioural therapy; Genetic counselling; Genetic testing; Genetics; Psycho education; Psychological risk; Psychosocial impact; Psychotherapy; Risk counselling

Indexed keywords

EID: 84886004002     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470975176.ch17     Document Type: Chapter

References (83)

1. Lerman, C., Daly, M., Masny, A. et al. (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology, 12, 843-850.
2. Appleton, S., Fry, A., Rees, G. et al. (2000) Psychosocial effects of living with an increased risk of breast cancer: an exploratory study using telephone focus groups. Psychooncology, 9, 511-521.
3. Bowen, D., McTiernan, A., Burke, W. et al. (1999) Participation in breast cancer risk counseling among women with a family history. Cancer Epidemiology Biomarkers and Prevention, 8, 581-585.
4. Codori, A.M., Petersen, G.M., Miglioretti, D.L. et al. (1999) Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiology Biomarkers and Prevention, 8, 345-351.
5. Rees, G., Fry, A. and Cull, A. (2001) A family history of breast cancer: women's experiences from a theoretical perspective. Social Science and Medicine, 52, 1433-1440.
6. Leventhal, H., Kelly, K. and Leventhal, E. (1995) Population risk, actual risk, perceived risk, and cancer control: a discussion. Journal of National Cancer Institute Monographs, 25, 81-85.
7. Kash, K.M. and Lerman, C. (1998) Psychological, social, and ethical issues in gene testing, in Psycho-Oncology (ed. J.C. Holland), Oxford University Press, New York, pp. 196-207.
8. Stiefel, F., Lehmann, A. and Guex, P. (1997) Genetic detection: the need for psychosocial support in modern cancer prevention. Support Care Cancer, 5, 461-465.
9. Black, W.C., Nease, R.F. Jr. and Tosteson, A.N. (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. Journal of National Cancer Institute, 87, 720-731.
10. Durfy, S.J., Bowen, D.J., McTiernan, A. et al. (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiology Biomarkers Prevention, 8, 369-375.
11. Esplen, M.J., Toner, B., Hunter, J. et al. (2000) A supportiveexpressive group intervention for women with a family history of breast cancer: results of a phase II study. Psychooncology, 9, 243-252.
12. Kash, K.M., Holland, J.C., Halper, M.S. et al. (1992) Psychological distress and surveillance behaviors of women with a family history of breast cancer. Journal of the National Cancer Institute, 84, 24-30.
13. Lerman, C., Lustbader, E., Rimer, B. et al. (1995) Effects of individualized breast cancer risk counseling: a randomized trial. Journal of the National Cancer Institute, 87, 286-292.
14. Edwards, A., Gray, J., Clarke, A. et al. (2008) Interventions to improve risk communication in clinical genetics: systematic review. Patient Education and Counseling, 71, 4-25.
15. Wellisch, D.K., Gritz, E.R., Schain, W. et al. (1991) Psychological functioning of daughters of breast cancer patients. Part I: daughters and comparison subjects. Psychosomatics, 32, 324-336.
16. Marteau, T.M. and Senior, V. (1997) Illness representations after the human genome project: the perceived role of genes in causing illness, in Perceptions of Illness and Treatment Current Psychological Research and Implications (eds K. Petrie and J. Weinman), Harwood Academic Press, Amsterdam, pp. 41-66.
17. Dorval, M., Patenaude, A.F., Schneider, K.A. et al. (2000) Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. Journal of Clinical Oncology, 18, 2135-2142.
18. van Oostrom, I., Meijers-Heijboer, H., Lodder, L.N. et al. (2003) Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. Journal of Clinical Oncology, 21, 3867-3874.
19. Esplen, M.J., Urquhart, C., Butler, K. et al. (2003) The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing. Journal of Psychosomatic Research, 55, 427-435.
20. Lerman, C., Peshkin, B.N., Hughes, C. et al. (1998) Family disclosure in genetic testing for cancer susceptibility: determinants and consequences. Journal of Health Care Law and Policy, 1, 352-371.
21. Esplen, M.J., Hunter, J., Leszcz, M. et al. (2004) A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer, 101, 2327-2340.
22. Vernon, S.W., Gritz, E.R., Peterson, S.K. et al. (1997) Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychology, 16, 73-86.
23. Meiser, B., Gleeson, M.A. and Tucker, K.M. (2000) Psychological impact of genetic testing for adult-onset disorders. An update for clinicians. Medical Journal of Australia, 172, 126-129.
24. DudokdeWit, A.C., Tibben, A., Duivenvoorden, H.J. et al., Rotterdam/Leiden Genetics Workgroup (1998) Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. American Journal of Medical Genetics, 75, 62-74.
25. Codori, A.M., Slavney, P.R., Young, C. et al. (1997) Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychology, 16, 36-50.
26. Lloyd, S.M., Watson, M., Oaker, G. et al. (2000) Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women. Psychooncology, 9, 473-485.
27. Metcalfe, K.A., Esplen, M.J., Goel, V. et al. (2004) Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psychooncology, 13, 14-25.
28. Elit, L., Esplen, M.J., Butler, K. et al. (2001) Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Familial Cancer, 1, 149-156.
29. Lerman, C., Hughes, C., Croyle, R.T. et al. (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine, 31, 75-80.
30. Watson, M., Foster, C., Eeles, R. et al. (2004) Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. British Journal of Cancer, 91, 1787-1794.
31. Smith, K.R., West, J.A., Croyle, R.T. et al. (1999) Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiology Biomarkers and Prevention, 8, 385-392.
32. Coyne, J.C., Benazon, N.R., Gaba, C.G. et al. (2000) Distress and psychiatric morbidity among women from highrisk breast and ovarian cancer families. Journal of Consulting and Clinical Psychology, 68, 864-874.
33. Wellisch, D.K. and Lindberg, N.M. (2001) A psychological profile of depressed and nondepressed women at high risk for breast cancer. Psychosomatics, 42, 330-336.
34. Trask, P.C., Paterson, A.G., Wang, C. et al. (2001) Cancerspecific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning. Psychooncology, 10, 349-360.
35. Coyne, J.C., Kruus, L., Racioppo, M. et al. (2003) What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?. American Journal of Medical Genetics A, 116A, 222-228.
36. Schwartz, M.D., Peshkin, B.N., Hughes, C. et al. (2002) Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Journal of Clinical Oncology, 20, 514-520.
37. Butow, P.N., Lobb, E.A., Meiser, B. et al. (2003) Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Medical Journal of Australia, 178, 77-81.
38. Meiser, B. (2005) Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology, 14, 1060-1074.
39. Struewing, J.P., Lerman, C., Kase, R.G. et al. (1995) Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiology Biomarkers and Prevention, 4, 169-173.
40. Cappelli, M., Surh, L., Humphreys, L. et al. (1999) Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clinical Genetics, 55, 419-430.
41. Esplen, M.J., Stuckless, N., Hunter, J. et al. (2009) The BRCA self-concept scale: a new instrument to measure selfconcept in BRCA1/2 mutation carriers. Psychooncology, 18, 1216-1229.
42. Cappelli, M., Surh, L., Walker, M. et al. (2001) Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. Psychology, Health and Medicine, 6, 323-335.
43. Lerman, C., Narod, S., Schulman, K. et al. (1996) BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. Journal of the American Medical Association, 275, 1885-1892.
44. Marteau, T.M. and Croyle, R.T. (1998) Psychological responses to genetic testing. British Medical Journal, 316, 693-696.
45. Maheu, C. and Thorne, S. (2008) Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience. Research in Nursing and Health, 31, 553-562.
46. Ardern-Jones, A., Kenen, R., Lynch, E. et al. (2010) Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives. Hereditary Cancer in Clinical Practice, 8, 1.
47. Dorval, M., Gauthier, G., Maunsell, E. et al. (2003) Are women with an inconclusive BRCA1/2 genetic test result falsely reassured?. Psycho-Oncology, 12, 166.
48. Foster, C., Watson, M., Moynihan, C. et al. (2004) Juggling roles and expectations: dilemmas faced by women talking to relatives about cancer and genetic testing. Psychology and Health, 19, 439-455.
49. Williams, J.K., Schutte, D.L., Holkup, P.A. et al. (2000) Psychosocial impact of predictive testing for Huntington disease on support persons. American Journal of Medical Genetics, 96, 353-359.
50. Tercyak, K.P., Peshkin, B.N., Streisand, R. et al. (2001) Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants. Psychooncology, 10, 336-346.
51. Evers-Kiebooms, G., Welkenhuysen, M., Claes, E. et al. (2000) The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education. Social Science and Medicine, 51, 831-841.
52. Decruyenaere, M., Evers-Kiebooms, G., Denayer, L. et al. (2000) Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling. European Journal of Human Genetics, 8, 130-136.
53. Braithwaite, D., Emery, J., Walter, F. et al. (2004) Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Journal of the National Cancer Institute, 96, 122-133.
54. Watson, M., Lloyd, S., Davidson, J. et al. (1999) The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. British Journal of Cancer, 79, 868-874.
55. Michie, S., Marteau, T.M. and Bobrow, M. (1997) Genetic counselling: the psychological impact of meeting patients' expectations. Journal of Medical Genetics, 34, 237-241.
56. Thewes, B., Meiser, B., Tucker, K. et al. (2003) Screening for psychological distress and vulnerability factors in women at increased risk for breast cancer: a review of the literature. Psychology Health and Medicine, 8, 289-303.
57. Kasparian, N.A., Wakefield, C.E., Meiser, B. (2007) Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. Journal of Genetic Counseling, 16, 693-712.
58. Tercyak, K.P., Demarco, T.A., Mars, B.D. et al. (2004) Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects. American Journal of Medical Genetics A, 131, 36-41.
59. van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H.J. et al. (2007) Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Education and Counseling, 65, 58-68.
60. van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H.J. et al. (2007) Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing. European Journal of Cancer, 43, 71-77.
61. Graves, K.D., Wenzel, L., Schwartz, M.D. et al. (2010) Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology Biomarkers and Prevention, 19, 648-654.
62. McInerney-Leo, A., Biesecker, B.B., Hadley, D.W. et al. (2004) BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. American Journal of Medical Genetics A, 130A, 221-227.
63. Miller, S.M., Roussi, P., Daly, M.B. et al. (2005) Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors. Health Education and Behaviour, 32, 654-667.
64. Appleton, S., Watson, M., Rush, R. et al. (2004) A randomised controlled trial of a psychoeducational intervention for women at increased risk of breast cancer. British Journal of Cancer, 90, 41-47.
65. Wakefield, C.E., Meiser, B., Homewood, J. et al. (2007) Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. Journal of Genetic Counseling, 16, 325-339.
66. Stacey, D., O'Connor, A.M., DeGrasse, C. et al. (2003) Development and evaluation of a breast cancer prevention decision aid for higher-risk women. Health Expectations, 6, 3-18.
67. van Roosmalen, M.S., Stalmeier, P.F., Verhoef, L.C. et al. (2004) Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. Journal of Clinical Oncology, 22, 3293-3301.
68. van Roosmalen, M.S., Stalmeier, P.F., Verhoef, L.C. et al. (2004) Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. British Journal of Cancer, 90, 333-342.
69. Wellisch, D.K., Hoffman, A., Goldman, S. et al. (1999) Depression and anxiety symptoms in women at high risk for breast cancer: pilot study of a group intervention. American Journal of Psychiatry, 156, 1644-1645.
70. Karp, J.B.K., Sullivan, M.D. and Massie, M.J. (1999) The prophylactic mastectomy dilemma: a support group for women at high genetic risk for breast cancer. Journal of Genetic Counseling, 8, 163-173.
71. Wang, C., Gonzalez, R., Milliron, K.J. et al. (2005) Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process. American Journal of Medical Genetics A, 134A, 66-73.
72. Phelps, C., Bennett, P., Iredale, R. et al. (2006) The development of a distraction-based coping intervention for women waiting for genetic risk information: a phase 1 qualitative study. Psychooncology, 15, 169-173.
73. Carlson, L.E., Speca, M., Patel, K.D. et al. (2003) Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosomatic Medicine, 65, 571-581.
74. Bennett, P., Wilkinson, C., Turner, J. et al. (2007) The impact of breast cancer genetic risk assessment on intentions to perform cancer surveillance behaviors. Journal of Genetic Counseling, 16, 617-623.
75. Beck, A.T. (1976) Cognitive Therapy and The Emotional Disorders, International Universities Press, New York.
76. Hunter, J.J., Maunder, R.G. and Gupta, M. (2007) Teaching consultation-liaison psychotherapy: assessment of adaptation to medical and surgical illness. Academic Psychiatry, 31, 367-374.
77. Maunder, R.G. and Hunter, J.J. (2008) Attachment relationships as determinants of physical health. Journal of American Academy of Psychoanalysis and Dynamic Psychiatry, 36, 11-32.
78. Weissman, M.M. and Markowitz, J.C. (1998) An overview of interpersonal psychotherapy, in Interpersonal Psychotherapy (ed. J. Markowitz), American Psychiatric Press, Washington, DC, pp. 1-33.
79. van Straten, A., Geraedts, A., Verdonck-de Leeuw, I. et al. (2010) Psychological treatment of depressive symptoms in patients with medical disorders: a meta-analysis. Journal of Psychosomatic Research, 69, 23-32.
80. Esplen, M.J., Toner, B., Hunter, J. et al. (1998) A group therapy approach to facilitate integration of risk information for women at risk for breast cancer. Canadian Journal of Psychiatry, 43, 375-380.
81. Spiegel, D. and Spira, J. (1991) Supportive-Expressive Group Therapy: A Treatment Manual of Psychosocial Intervention for Women with Recurrent Breast Cancer, Psychosocial Treatment Laboratory, Stanford University School of Medicine, Sanford, CA.
82. Spiegel, D., Bloom, J.R., Kraemer, H.C. et al. (1989) Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2, 888-891.
83. Leszcz, M. and Goodwin, P.J. (1998) The rationale and foundations of group psychotherapy for women with metastatic breast cancer. International Journal of Group Psychotherapy, 48, 245-273.